PLN-74809是一种口服双选择性αvβ6/αvβ1抑制剂，在治疗特发性肺纤维化(IPF)的2期临床试验中，每日一次给药可持续降低健康受试者肺部转化生长因子β (TGF-β)活性

{"title":"PLN-74809是一种口服双选择性αvβ6/αvβ1抑制剂，在治疗特发性肺纤维化(IPF)的2期临床试验中，每日一次给药可持续降低健康受试者肺部转化生长因子β (TGF-β)活性","authors":"G. Cosgrove, M. Decaris, S. Wong, E. Park, S. Turner, E. Adegbite, E. Lefebvre","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5251","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":179165,"journal":{"name":"D30. THE INJURED LUNG: MECHANISMS AND THERAPEUTIC TARGETS","volume":"29 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"PLN-74809, an Oral, Dual-Selective αvβ6/αvβ1 Inhibitor in Phase 2 Clinical Trials for Idiopathic Pulmonary Fibrosis (IPF), Sustainably Reduces Transforming Growth Factor Beta (TGF-β) Activity in the Lungs of Healthy Participants with Once-Daily Dosing\",\"authors\":\"G. Cosgrove, M. Decaris, S. Wong, E. Park, S. Turner, E. Adegbite, E. Lefebvre\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5251\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":179165,\"journal\":{\"name\":\"D30. THE INJURED LUNG: MECHANISMS AND THERAPEUTIC TARGETS\",\"volume\":\"29 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"D30. THE INJURED LUNG: MECHANISMS AND THERAPEUTIC TARGETS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5251\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"D30. THE INJURED LUNG: MECHANISMS AND THERAPEUTIC TARGETS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5251","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}